[Transcatheter aortic valve prosthesis implantation (TAVI)]

Jeppsson A, Selimovic N, Ioanes D, Bergh N, Gabel J, Jivegard L, Strandell A, Daxberg EL, Svanberg T
Record ID 32011001692
Swedish
Authors' objectives:

How does transcatheter aortic valve prosthesis implantation (TAVI) affect quality of life, and morbidity, compared with medical treatment or open surgery, among adult patients with aortic valvular disease?

Authors' recommendations: TAVI is a minimally invasive technique for patients with severe aortic stenosis, that have been considered inoperable, or with a high surgical risk. Hemodynamic results following TAVI have been promising, but the level of evidence for all studied outcomes is insufficient for treatment of inoperable, or high surgical risk patients with severe aortic stenosis. The method is expensive and comparisons to currently available non-invasive treatment are absent. Serious complications occur with TAVI in patients considered inoperable, or with a high surgical risk.
Details
Project Status: Completed
Year Published: 2010
English language abstract: An English language summary is available
Publication Type: Not Assigned
MeSH Terms
  • Aortic Valve
  • Aortic Valve Stenosis
Contact
Organisation Name: The Regional Health Technology Assessment Centre
Contact Address: The Regional Health Technology Assessment Centre, Region Vastra Gotaland, HTA-centrum, Roda Straket 8, Sahlgrenska Universitetssjukhuset, 413 45 GOTHENBORG, Sweden
Contact Name: hta-centrum@vgregion.se
Contact Email: hta-centrum@vgregion.se
Copyright: The Regional Health Technology Assessment Centre (HTA-centrum), Region Vastra Gotaland
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.